Ciclesonide is effective in protecting against exercise-induced bronchoconstriction

In a double-blind, randomized, 2-period cross-over study with two parallel arms, 4 doses of ciclesonide were compared: 40 and 160 μg in one arm, and 80 and 320 μg in the other arm (doses are ex-actuator MDI; equivalent to 50 to 400 μg ex-valve).

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2005-02, Vol.115 (2), p.S1-S1
Main Authors: Subbarao, P.J., Duong, M., Otis, J., Obminski, G., Adelroth, E., Pedersen, S., Inman, M., O'Byrne, P.M.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In a double-blind, randomized, 2-period cross-over study with two parallel arms, 4 doses of ciclesonide were compared: 40 and 160 μg in one arm, and 80 and 320 μg in the other arm (doses are ex-actuator MDI; equivalent to 50 to 400 μg ex-valve).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2004.12.020